OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week confirmed it is set to launch a Phase 2b/3 clinical trial for neuropathic corneal pain, following ...

Virtuix Holdings Inc (NASDAQ:VTIX) earlier this week marked a significant milestone with its listing on the Nasdaq under the ticker symbol VTIX, as ...

CEO Alberto Rosende talked with Proactive about the company's mission to reshape the U.S. critical minerals supply chain. In ...

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) this week reaffirmed its focus on capital efficiency and pipeline advancement following a ...

CEO Sam Tabar talked with Proactive about the company's major strategic shift in 2025 and its positioning at the ...

CEO Brian Fowler joined Proactive to discuss discussed the recent approval of up to $4 million in funding from ...